Timing matters in macrophage/CD4+ T cell interactions: an agent-based model comparing <i>Mycobacterium tuberculosis</i> host-pathogen interactions between latently infected and naïve individuals

Tuberculosis (TB), caused by <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>), remains a significant health challenge. Clinical manifestations of TB exist across a spectrum with a majority of infected individuals remaining asymptomatic, commonly referred to as latent TB infection (LTBI). <i>In vitro</i> models have demonstrated that cells from individuals with LTBI can better control <i>Mtb</i> growth and form granuloma-like structures more quickly, compared to cells from uninfected (<i>Mtb</i>-naïve) individuals. These <i>in vitro</i> results agree with animal and clinical evidence that LTBI protects, to some degree, against reinfection. However, the mechanisms by which LTBI might offer protection against reinfection remain unclear, and quantifying the relative contributions of multiple control mechanisms is challenging using experimental methods alone. To complement <i>in vitro</i> models, we have developed an <i>in silico</i> agent-based model to help elucidate host responses that might contribute to protection against reinfection. Our simulations indicate that earlier contact between macrophages and CD4+ T cells leads to LTBI simulations having more activated CD4+ T cells and, in turn, more activated infected macrophages, all of which contribute to a decreased bacterial load early on. Our simulations also demonstrate that granuloma-like structures support this early macrophage activation in LTBI simulations. We find that differences between LTBI and <i>Mtb</i>-naïve simulations are driven by TNFα and IFNγ-associated mechanisms as well as macrophage phagocytosis and killing mechanisms. Together, our simulations show how important the timing of the first interactions between innate and adaptive immune cells is, how this impacts infection progression, and why cells from LTBI individuals might be faster to respond to reinfection.IMPORTANCETuberculosis (TB) remains a significant global health challenge, with millions of new infections and deaths annually. Despite extensive research, the mechanisms by which latent TB infection (LTBI) confers protection against reinfection remain unclear. In this study, we developed an <i>in silico</i> agent-based model to simulate early immune responses to <i>Mycobacterium tuberculosis</i> infection based on experimental <i>in vitro</i> infection of human donor cells. Our simulations reveal that early interactions between macrophages and CD4+ T cells, driven by TNFα and IFNγ, are critical for bacterial control and granuloma formation in LTBI. These findings offer new insights into the immune processes involved in TB, which could inform the development of targeted vaccines and host-directed therapies. By integrating experimental data with computational predictions, our research provides a robust framework for understanding TB immunity and guiding future interventions to mitigate the global TB burden.

Authors

Institutions

Publication Details

Journal
mSystems
Published
2025-02-07
DOI
https://doi.org/10.1128/msystems.01290-24
Citations
4
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
5.58

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Timing matters in macrophage/CD4+ T cell interactions: an agent-based model comparing Mycobacterium tuberculosis host-pathogen interactions between latently infected and naïve individuals

Eusondia Arnett, Larry S. Schlesinger, Alexa Petrucciani, Elsje Pienaar et al.
4 citations
mSystems
Tuberculosis Research and Epidemiology
5.58
article

Timing matters in macrophage/CD4+ T cell interactions: an agent-based model comparing Mycobacterium tuberculosis host-pathogen interactions between latently infected and naïve individuals

Eusondia Arnett, Larry S. Schlesinger, Alexa Petrucciani, Elsje Pienaar, Alexis Hoerter, Jordan R. Bonifacio
article en
4 citations

Abstract

Tuberculosis (TB), caused by <i>Mycobacterium tuberculosis</i> (<i>Mtb</i>), remains a significant health challenge. Clinical manifestations of TB exist across a spectrum with a majority of infected individuals remaining asymptomatic, commonly referred to as latent TB infection (LTBI). <i>In vitro</i> models have demonstrated that cells from individuals with LTBI can better control <i>Mtb</i> growth and form granuloma-like structures more quickly, compared to cells from uninfected (<i>Mtb</i>-naïve) individuals. These <i>in vitro</i> results agree with animal and clinical evidence that LTBI protects, to some degree, against reinfection. However, the mechanisms by which LTBI might offer protection against reinfection remain unclear, and quantifying the relative contributions of multiple control mechanisms is challenging using experimental methods alone. To complement <i>in vitro</i> models, we have developed an <i>in silico</i> agent-based model to help elucidate host responses that might contribute to protection against reinfection. Our simulations indicate that earlier contact between macrophages and CD4+ T cells leads to LTBI simulations having more activated CD4+ T cells and, in turn, more activated infected macrophages, all of which contribute to a decreased bacterial load early on. Our simulations also demonstrate that granuloma-like structures support this early macrophage activation in LTBI simulations. We find that differences between LTBI and <i>Mtb</i>-naïve simulations are driven by TNFα and IFNγ-associated mechanisms as well as macrophage phagocytosis and killing mechanisms. Together, our simulations show how important the timing of the first interactions between innate and adaptive immune cells is, how this impacts infection progression, and why cells from LTBI individuals might be faster to respond to reinfection.IMPORTANCETuberculosis (TB) remains a significant global health challenge, with millions of new infections and deaths annually. Despite extensive research, the mechanisms by which latent TB infection (LTBI) confers protection against reinfection remain unclear. In this study, we developed an <i>in silico</i> agent-based model to simulate early immune responses to <i>Mycobacterium tuberculosis</i> infection based on experimental <i>in vitro</i> infection of human donor cells. Our simulations reveal that early interactions between macrophages and CD4+ T cells, driven by TNFα and IFNγ, are critical for bacterial control and granuloma formation in LTBI. These findings offer new insights into the immune processes involved in TB, which could inform the development of targeted vaccines and host-directed therapies. By integrating experimental data with computational predictions, our research provides a robust framework for understanding TB immunity and guiding future interventions to mitigate the global TB burden.

mSystemsVol. 10(3)
Texas Biomedical Research Institute (US), Regenstrief Institute (US), Purdue University West Lafayette (US)
National Science Foundation, Pharmaceutical Research and Manufacturers of America Foundation, Purdue University, Indiana Clinical and Translational Sciences Institute, Texas Biomedical Research Institute, National Institutes of Health, University of California, San Diego, National Center for Advancing Translational Sciences
Good health and well-being
Openalex Percentile: Top 5%
Tuberculosis Research and Epidemiology
5.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.